Vitamin B1 (Thiamine)
The energy-metabolism spark plug — vital when deficient, inert when you're not
What is Vitamin B1 (Thiamine)?
Vitamin B1 (Thiamine) is a vitamin used for corrects and prevents deficiency syndromes — beriberi (cardiac and neuropathic) and, with prompt iv dosing, wernicke-korsakoff syndrome in alcohol-use disorder. NutriDex grades the human evidence as Strong. Thiamine (vitamin B1) is an essential water-soluble vitamin whose active form, thiamine pyrophosphate, is a coenzyme for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and transketolase — reactions central to carbohydrate metabolism and ATP production. Deficiency causes beriberi (wet/cardiac and dry/neuropathic forms) and, classically in alcohol-use disorder, Wernicke-Korsakoff syndrome; high-risk groups include heavy drinkers, those on chronic loop diuretics, bariatric-surgery and critically ill patients. In non-deficient people, supplementation trials are largely null: a 2024 meta-analysis of 7 RCTs found no improvement in LVEF in chronic heart failure, and high-dose thiamine did not relieve chronic fatigue versus placebo in a crossover RCT. The lipid-soluble derivative benfotiamine shows modest, dose-dependent symptom benefit in diabetic polyneuropathy but evidence remains limited.
Purported Benefits
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
| Outcome | Evidence | Effect | Studies |
|---|---|---|---|
| Treatment of deficiency syndromes (beriberi, Wernicke-Korsakoff)IV/oral thiamine reverses beriberi and Wernicke encephalopathy; evidence is observational/case-series but consistent, optimal dose still undefined. | Strong | ↑ benefit · large | 3 |
| Repletion in high-risk groups (alcohol, diuretics, bariatric, refeeding)Systematic reviews confirm deficiency is common in these groups and repletion is indicated; benefit is preventing deficiency, not enhancement. | Moderate | ↑ benefit · moderate | 2 |
| Diabetic polyneuropathy (benfotiamine)Single RCT (BENDIP, n=165) showed dose-dependent symptom relief, but per-protocol p=0.033 / ITT p=0.055; applies to benfotiamine, not standard thiamine. | Preliminary | ↑ benefit · small | 1 |
| Heart failure (LVEF in non-deficient)2024 meta-analysis of 7 RCTs (n=274) found no LVEF improvement (WMD 1.65%, p=0.24) beyond correcting documented deficiency. | Moderate | — no effect · negligible | 1 |
| Chronic fatigue / energy in replete individualsCrossover RCT in primary biliary cholangitis found high-dose thiamine no better than placebo for fatigue; contradicts 'energy vitamin' marketing. | Preliminary | — no effect · negligible | 1 |
| Septic shock mortalityMeta-analysis of RCTs with trial sequential analysis found thiamine alone did not reduce mortality (RR 0.87, 95% CI 0.65-1.16). | Moderate | — no effect · negligible | 1 |